Trending
- London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’ | Pharmaceuticals industry
- ERO1a fosters glioblastoma aggressiveness and metabolic flexibility by regulating mitochondria-associated membrane dynamics
- NHS staff battling wave of food supplement disinformation | NHS
- Tumour deposits in colorectal carcinoma are associated with immune evasion and dose-dependent adverse prognosis beyond nodal status
- Development of surfactin-based nanocarrier for targeted doxorubicin delivery
- BrECADD Improves PFS Vs Nivolumab/AVD in Advanced-Stage Hodgkin Lymphoma
- 70 Real-World Outcomes and Toxicity of Trastuzumab Deruxtecan in Older Adults With Breast Cancer: A Mayo Clinic Multi-Site Analysis
- 69 Assessing the Impact and Efficacy of Anthracyclines and Trastuzumab Alternatives on Potential Cardiotoxicity in Breast Cancer Patients
Sunday, June 14